Car­olyn Bertozzi’s lat­est biotech de­buts with $30M seed round and a sug­ary spin on im­munother­a­py

Val­o­ra Ther­a­peu­tics has $30 mil­lion to jump-start re­search on im­munother­a­pies based on sug­ars — the kind that dots cell sur­faces and helps dev­as­tat­ing can­cers evade im­mune …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER